Blogs

 

Latest News

Welcome to HealthBanks

Welcome to HealthBanks

Welcome to HealthBanks   The HealthBanks network was created in response to the rapidly growing stem cell and gene therapy fields. Advancements being made in these fields are transforming the face of modern medicine, providing hope to families and helping give those...

ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment

ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment

RANCHO CORDOVA, Calif., Jan. 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that ImmuneCyte Life Sciences, Inc. (“ImmuneCyte”), an 80/20 joint...

Immune Cell Banking News

COVID-19 and Immune Cells

Coronaviruses cover a wide variety of viruses that infect humans and animals. They include viruses as mild as the common cold all the way to deadly viruses like MERS, SARS, and COVID-19. The entire world has been altered since COVID-19 was recognized as a pandemic in...

ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment

ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment

RANCHO CORDOVA, Calif., Jan. 3, 2020 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that ImmuneCyte Life Sciences, Inc. (“ImmuneCyte”), an 80/20 joint...

Cord Blood Banking News

Why is Cord Blood Banking Necessary Today?

Many of us are familiar with harvesting bone marrow for stem cells, but what about stem cells from umbilical cords? Cord blood banking is becoming an increasingly common practice, and for good reason. Umbilical cords are rich in stem cells, and extracting cord blood...

The Promise and Price of Cellular Therapies

The Promise and Price of Cellular Therapies

From newyorker.com New “living drugs”—made from a patient’s own cells—can cure once incurable cancers. But can we afford them? It matters that the first patients were identical twins. Nancy and Barbara Lowry were six years old, dark-eyed and dark-haired, with...

Subscribe to Our Newsletter & Special Promotions

Disclaimer: The use of cord blood and immune cells is determined by the treating physician and manufacturer of the final products and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the immune cells should be further modified or expanded. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available. Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Immune cells has established uses in certain blood cancer treatment; however, its use in solid cancer is still being researched. There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.

HealthBanks cryopreserves immune cells that have been collected from an individual for potential future cellular therapy use. HealthBanks does not provide medical advice, treatment or care. The use of cryopreserved cells for future immunotherapies is not guaranteed. Much is yet unknown about the future of immunotherapy and the immune cells that have been cryopreserved. The use of cryopreserved cells by commercial manufacturers for CAR-T therapy production is not currently approved by the FDA. There is active research ongoing, however, there is no guarantee that your cryopreserved cells will have a future therapeutic use. Only your health care professional can help you evaluate whether your cells might be used and if so, how they might be used. HealthBanks and its shareholders, directors, officers, agents, employees, affiliates, network of providers and provider facilities, will not be liable to you or any other party for claims relating to sample collection or if your cells cannot be used, or if any harm, injury, damage or loss results from the use of your cells. For more information, please refer to HealthBanks Service Agreement.